In a report released today, Steve Scala from TD Cowen maintained a Buy rating on AstraZeneca (AZN – Research Report). The company’s shares closed last Friday at $63.23. Don't Miss our Black Friday ...

Spero Therapeutics (SPRO – Research Report) received a Hold rating and price target from TD Cowen analyst Ritu Baral yesterday. The ...

John Kernan, TD Cowen managing director and retail analyst, joins 'Money Movers' to discuss how important Chinese exposure is ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

As previously reported, TD Cowen analyst Mario Mendonca upgraded Scotiabank (BNS) to Buy from Hold with an C$80 price target The firm, which believes ROE is “among the most important financial ...